4
Changes in Ownership
RESMED INC Filed Acc 0001127602-24-014978
Chief Financial Officer sold 13,000 shares at $211.37 ($2,747,810)
- Chief Financial Officer acquired 12,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sandercock Brett Chief Financial Officer | 2024-05-08 | Option exercise 10b5-1 | +12,000 | $101.64 | $1,219,680 | 105,056 | D: show line 1 in the form |
| Sandercock Brett Chief Financial Officer | 2024-05-08 | Sale 10b5-1 | −13,000 | $211.37 | $2,747,810 | 92,056 | D: show line 2 in the form |
| Open-market sales · 13,000 sh · avg $211.37 · $2,747,810 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Sandercock Brett Chief Financial Officer | 2024-05-08 | Option exercise · ResMed Common Stock Options 10b5-1 | −12,000 | 10,883 | D: show line 3 in the form |
Loading xslF345X05/form4.xml…